Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease
…, A Hassan, U Klaar, S Schwarzacher, D Glogar… - Atherosclerosis, 1997 - Elsevier
Flow-mediated vasodilation (FMD) of systemic arteries, a non-invasive parameter of endothelial
function, is correlated with cardiovascular risk factors. The relationship between FMD …
function, is correlated with cardiovascular risk factors. The relationship between FMD …
Transapical minimally invasive aortic valve implantation: multicenter experience
…, MT Kasimir, M Doss, MA Borger, G Schuler, D Glogar… - Circulation, 2007 - Am Heart Assoc
Background— To evaluate initial multicenter results with minimally invasive transapical
aortic valve implantation (TAP-AVI) for high risk patients with aortic stenosis. Methods and …
aortic valve implantation (TAP-AVI) for high risk patients with aortic stenosis. Methods and …
Direct intramyocardial plasmid vascular endothelial growth factor-A165gene therapy in patients with stable severe angina pectoris: A randomized double-blind …
…, E Jørgensen, A Rück, K Tägil, D Glogar… - Journal of the American …, 2005 - jacc.org
Objectives : In the Euroinject One phase II randomized double-blind trial, therapeutic
angiogenesis of percutaneous intramyocardial plasmid gene transfer of vascular endothelial …
angiogenesis of percutaneous intramyocardial plasmid gene transfer of vascular endothelial …
Isolation of Borrelia burgdorferi from the Myocardium of a Patient with Long-Standing Cardiomyopathy
…, J Klein, R Bittner, D Glogar - New England Journal of …, 1990 - Mass Medical Soc
LYME borreliosis (or Lyme disease) is a systemic disorder caused by the spirochete Borrelia
burgdorferi, a newly discovered species of borrelia. The disease usually begins with a …
burgdorferi, a newly discovered species of borrelia. The disease usually begins with a …
Intracoronary thrombectomy with the X-sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary …
…, S Denk, T Stefenelli, B Syeda, G Maurer, D Glogar… - Circulation, 2002 - Am Heart Assoc
Background— In patients with acute coronary syndrome (ACS), percutaneous coronary
intervention (PCI) may cause thrombus dislodgment followed by reduced flow and impaired …
intervention (PCI) may cause thrombus dislodgment followed by reduced flow and impaired …
Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified …
…, J Wojta, K Huber, D Glogar - Circulation …, 2008 - Am Heart Assoc
Background— Porcine bone marrow-derived mesenchymal stem cells (MSCs) were stably
transfected with a lentiviral vector for transgene expression of the trifusion protein renilla …
transfected with a lentiviral vector for transgene expression of the trifusion protein renilla …
Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study
…, G Sodeck, A Kaider, G Maurer, D Glogar - Nature Clinical Practice …, 2009 - nature.com
Background Combined intracoronary and intramyocardial administration might improve
outcomes for bone-marrow-derived stem cell therapy for acute myocardial infarction (AMI). We …
outcomes for bone-marrow-derived stem cell therapy for acute myocardial infarction (AMI). We …
Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque
…, H Lass, W Mosgoeller, DH Glogar… - Blood, The Journal …, 2002 - ashpublications.org
Defined angiographically, no-reflow (NR) manifests as an acute reduction in coronary flow
in the absence of epicardial vessel obstruction. One candidate protein to cause coronary NR …
in the absence of epicardial vessel obstruction. One candidate protein to cause coronary NR …
NOGA-guided analysis of regional myocardial perfusion abnormalities treated with intramyocardial injections of plasmid encoding vascular endothelial growth factor A …
…, G Mundigler, J Novak, H Sochor, G Maurer, D Glogar… - Circulation, 2005 - Am Heart Assoc
Background— The aim of this substudy of the EUROINJECT-ONE double-blind randomized
trial was to analyze changes in myocardial perfusion in NOGA-defined regions with …
trial was to analyze changes in myocardial perfusion in NOGA-defined regions with …
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121. 10NH) gene therapy in patients with …
…, S Nikol, HE Bøtker, M Gyöngyösi, D Glogar… - … : journal of EuroPCR …, 2011 - europepmc.org
Aims Genes encoding vascular endothelial growth factor (VEGF) can potentially augment
myocardial perfusion in patients with coronary artery disease (CAD). We conducted a …
myocardial perfusion in patients with coronary artery disease (CAD). We conducted a …